Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Dow
Cantor Fitzgerald
Colorcon
Express Scripts
Cipla
Chinese Patent Office
Healthtrust
Federal Trade Commission

Generated: May 27, 2018

DrugPatentWatch Database Preview

MAXAQUIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Maxaquin patents expire, and what generic alternatives are available?

Maxaquin is a drug marketed by Pharmacia and is included in one NDA.

The generic ingredient in MAXAQUIN is lomefloxacin hydrochloride. There is one drug master file entry for this compound. Additional details are available on the lomefloxacin hydrochloride profile page.
Summary for MAXAQUIN
Drug patent expirations by year for MAXAQUIN
Synonyms for MAXAQUIN
(+-)-1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid monohydrochloride
(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride
079L528
1-ethyl-6,8-bis(fluoranyl)-7-(3-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride
1-ethyl-6,8-difluor-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydrochinolin-3-carbons
1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Hydrochloride
1-ethyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid hydrochloride
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid hydrochloride
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid hydrochloride
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrochloride
2521AH
3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride, (+-)-
3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride
98079-51-7 (Parent)
98079-52-8
A845801
A845802
AB1009378
AC1L2A47
AC1Q3CB3
AK-51350
AKOS015895388
AN-34635
API0005240
AX8136641
Bareon
BG0239
BR-51350
C-21486
C08053
C17H19F2N3O3.ClH
C17H19F2N3O3.HCl
C17H20ClF2N3O3
CAS-98079-52-8
CC-30023
CCG-39698
CCRIS 2581
CHEBI:6518
CHEMBL1728
CM14476
CM14477
CS-2566
D00873
DSSTox_CID_25527
DSSTox_GSID_45527
DSSTox_RID_80931
DTXSID2045527
EU-0100678
FT-0630997
GA2013
H534
HMS1568P17
HMS1921F20
HY-B0455
I06-0638
KS-1238
L 2906
L-6500
L0216
Logiflox
Lomebact
Lomefloxacin (hydrochloride)
Lomefloxacin HCl
Lomefloxacin HCl (Maxaquin)
Lomefloxacin hydrochloride
Lomefloxacin hydrochloride (JAN/USAN)
Lomefloxacin hydrochloride (Maxaquin)
Lomefloxacin hydrochloride [USAN:JAN]
Lomefloxacin monohydrochloride
Lomefloxacin monohydrochloride, Antibiotic for Culture Media Use Only
Lomefloxacinhydrochloride
LP00678
LS-141572
M-7526
Maxaquin (TN)
Maxaquine
Mazaquin
MFCD00214312
MolPort-003-666-401
NCGC00015603-08
NCGC00016964-01
NCGC00016964-02
NCGC00094038-01
NCGC00094038-02
NCGC00094038-03
NCGC00261363-01
NSC-758168
NSC758168
NY 198
Ny-198
Okacin
Okacyn
Pharmakon1600-01502037
Prestwick_581
PubChem23948
s2539
SC-47111
SCHEMBL42051
SPECTRUM1502037
SR-01000075959
SR-01000075959-1
ST24027089
ST51051235
Tox21_110716
Tox21_110716_1
Tox21_113154
Tox21_500678
Uniquin

US Patents and Regulatory Information for MAXAQUIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia MAXAQUIN lomefloxacin hydrochloride TABLET;ORAL 020013-001 Feb 21, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Johnson and Johnson
QuintilesIMS
US Department of Justice
Chubb
Federal Trade Commission
Cerilliant
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.